Hepatitis A virus seroprevalence among children and adolescents in a high‑burden HIV setting in urban South Africa

Show simple item record

dc.contributor.author Du Plessis, Nicolette Marie
dc.contributor.author Mazanderani, Ahmad Haeri
dc.contributor.author Motaze, Nkengafac Villyen
dc.contributor.author Ngobese, Makhosazane
dc.contributor.author Avenant, Theunis Johannes
dc.date.accessioned 2023-02-10T06:03:59Z
dc.date.available 2023-02-10T06:03:59Z
dc.date.issued 2022-11-30
dc.description DATA AVAILABILITY : Raw data were generated at Kalafong Provincial Tertiary Hospital and the University of Pretoria. Derived data supporting the fndings of this study are available from the corresponding author [NdP] on request. en_US
dc.description.abstract Hepatitis A virus (HAV) infection is one of the most important global causes of viral hepatitis. Recent reviews suggested that HAV endemicity in South Africa could shift from high to intermediate. A hospital-based HAV seroprevalence study was conducted between February 2018 and December 2019 in Pretoria, South Africa. Systematic sampling was performed on children and adolescents (1–15 years) who attended outpatient services. Participants with a known HIV status and valid HAV serology results were included. Of the 1220 participants, the median age was 7 years (IQR: 4–11), with 648 (53.11%) males and 572 (46.89%) females. Of 628 (51.48%) HIV-infected participants, most (329, 71.83%) were both immunologically and virologically controlled or had low-level viremia (74, 16.16%). Almost three-quarters (894, 73.28%) were living in formal dwellings, and just over half (688, 56.39%) had access to clean water sources inside the house. Increasing age was associated with testing HAV IgG-positive (OR 1.25; 95% CI 1.20–1.30, p < 0.001), with 19.8% of participants one year of age compared with 86.7% of participants 15 years of age. This study suggests that South Africa has an intermediate HAV seroprevalence, with rates < 90% by 10 years of age (68.6%). Increased age and informal dwellings are statistically associated with HAV seropositivity, while HIV status does not significantly influence HAV seropositivity. en_US
dc.description.department Paediatrics and Child Health en_US
dc.description.librarian am2023 en_US
dc.description.sponsorship A Research Grant by Sanofi Pasteur. en_US
dc.description.uri http://www.nature.com/scientificreports en_US
dc.identifier.citation Du Plessis, N.M., Mazanderani, A.H., Motaze, N.V. et al. 2022, 'Hepatitis A virus seroprevalence among children and adolescents in a high‑burden HIV setting in urban South Africa', Scientific Reports, vol. 12, art. 20688, pp. 1-6, doi : 10.1038/s41598-022-25064-x. en_US
dc.identifier.issn 2045-2322 (online)
dc.identifier.other 10.1038/s41598-022-25064-x
dc.identifier.uri https://repository.up.ac.za/handle/2263/89383
dc.language.iso en en_US
dc.publisher Nature Research en_US
dc.rights © The Author(s) 2022. This article is licensed under a Creative Commons Attribution 4.0 International License. en_US
dc.subject Infection en_US
dc.subject Viral hepatitis en_US
dc.subject South Africa (SA) en_US
dc.subject Hepatitis A virus (HAV) en_US
dc.subject Human immunodeficiency virus (HIV) en_US
dc.subject Children en_US
dc.subject Adolescents en_US
dc.title Hepatitis A virus seroprevalence among children and adolescents in a high‑burden HIV setting in urban South Africa en_US
dc.type Article en_US


Files in this item

This item appears in the following Collection(s)

Show simple item record